During March 2009, we evaluated the hemostatic profile and platelet indices of 18 Arabian sand gazelles (Gazella subgutturosa marica) and compared the results with those from humans and camels (Camelus dromedarius). Gazelles and camels had shorter activated partial thromboplastin times, lower proconvertin and higher antihemophilic factor coagulation activity, and plasma fibrinogen levels than humans. Prothrombin time was longer in sand gazelles and shorter in camels than it was in humans. Plasma thromboplastin component, Stuart factor, and plasma thromboplastin antecedent were similar in gazelles, humans, and camels, whereas the platelet count of the sand gazelle was significantly higher than it was for camels and humans.
INTRODUCTION
Coagulation protects animals from excessive loss of blood and fluids by sealing the sites of injury and restoring vascular integrity. The processes of clot formation and fibrinolysis involve highly complex and interdependent cellular, vascular, enzymatic, and regulatory events (Smith, 2009) . The extensive quantitative differences in coagulation systems among mammal species (Gentry, 2004) imply the need for species-specific studies of coagulation properties.
Blood coagulation has been most extensively studied in humans. Several studies have also been carried out on the hemostatic profile of domestic and common laboratory animals (Gentry, 2004) . Because of the lack of species-specific laboratory reagents, these studies are usually carried out using the same diagnostics employed for measuring clotting factors in human plasma. With the exception of dromedary camels (Camelus dromedarius; Hussein et al., 1992) and more recently oryx (Oryx leucoryx; Hussein et al., 2009a) , the coagulation profiles of desert mammals have received little or no attention. Studies on dromedaries have shown that they have shorter prothrombin time (PT) and activated partial thromboplastin time (APTT) and higher factor VIII:C activity than humans do (Hussein et al., 1992) and that their platelets are less sensitive to in vitro heating than human platelets are (Al Gumlas et al., 2008) . These findings suggested that camels might have a more active hemostatic system than humans, which could be a protective physiologic adaptation against excessive blood loss during severe desert drought (Abdelgadir et al., 2009) . If that is true, then it might be expected to apply to other species of desert ungulates, such as sand gazelles (Gazella subgutturosa marica).
To our knowledge, there is no published study on the hemostatic and thrombotic parameters of gazelles, apart from sparse data on platelet counts (Yarlioglu et al., 2004) and one study of the Speke gazelle (Gazella spekei) in which only the PT, APTT, and total platelet count were reported (Travis and Eby, 2006) . Other coagulation parameters remain undescribed for the genus Gazella. The objective of this study was to evaluate clotting times, coagulation factors, and platelet indices of the Arabian sand gazelle (Ga-zella subgutturosa marica). Samples from dromedary camels (Camelus dromedarius) and human volunteers were included for comparative purposes.
MATERIALS AND METHODS

Samples
Fifteen adult, nonpregnant, female sand gazelles and three adult, male sand gazelles, ages 2-5 yr and weighing 18-22 kg, were investigated during March 2009. These animals were born and kept in captivity at the King Khalid Wildlife Research Center near Riyadh, Saudi Arabia (24u419N, 46u429E). They were fed on a diet consisting of dried alfalfa (Medicago sativa L.) and commercial concentrate (16% protein), with free access to water. The dromedaries comprised 20 naturally grazing camels, aged 2-4 yr.
Two blood samples were collected by jugular venipuncture from each gazelle and each camel, while the animal was manually restrained. One sample was collected in an Ethylenediaminetetraacetic acid-dipotassium (EDTA-K 2 ) Vacutainer tube (Becton Dickinson and Company, Franklin Lakes, New Jersey, USA) for hematology and platelet index determinations, whereas the other sample was collected in a tube containing 3.2% trisodium citrate (0.11 M; Becton Dickinson) to give a citrate to blood ratio of 1:9 for the determination of coagulation parameters. Following collection, the tubes were gently inverted to ensure mixing of the sample. Whole-blood samples were analyzed within 2 hr of collection. The plasma was separated by centrifuging citrated blood samples at 3,500 3 G for 15 min at 4 C, transferred into plastic tubes, and frozen at 240 C for subsequent analysis. Whole and citrated blood samples were also collected from 10 male, human volunteers (20-23 yr old) after obtaining signed, informed consent.
Coagulation tests
Fibrinogen concentration, PT, APTT, and proconvertin (factor VII), antihemophilic factor coagulation activity (factor VIII:C), plasma thromboplastin component (factor IX), Stuart factor (factor X), and plasma antecedent (factor XI) were measured in paired citrated plasma using an automated STA Compact Coagulation Analyzer (Diagnostic Stago, Roche, Basilea, Switzerland) and commercially available reagents. The PT was determined by adding 0.2 ml rabbit thromboplastin reagent (Simplastin; Organon Teknika Corp., Durham, North Carolina, USA) to 0.1 ml citrated plasma, whereas APTT was measured by adding 0.1 ml actin-activated cephaloplastin reagent (Organon Teknika) to 0.1 ml of plasma and mixed with 0.1 ml CaCl 2 solution. Plasma samples for determination of both PT and APTT were incubated at 37 C for 3 min before adding respective reagents. Control values for PT and APTT were based on citrated human reference plasma (Baxter Diagnostics, Deerfield, Illinois, USA). Fibrinogen concentration was assayed using a commercial STA kit (Diagnostic Stago, Roche). The PT, APTT, and fibrinogen levels were measured in the clot-detection system of the STA analyzer. Intra-assay coefficients of variation for PT, APTT, and fibrinogen were 2.4, 3.3, and 2.2%, respectively.
Biological activity of individual coagulation factors was determined using substrates of human plasma deficient in either factor VII, VIII:C, IX, or X (Organon Teknika), and canine plasma deficient in factor XI (Dade Actin; Baxter Diagnostics). Activity of these factors in test samples was determined by adding the corresponding factor-deficient substrate to the sample, followed by the addition of Simplastin reagent for factors VII and X and cephaloplastin reagent for the remaining factors (VIII:C, IX, and XI). The mixture was incubated at 37 C for 3 min, and the clotting time was recorded.
Manufacturer's recommended reagents and procedures were used in all tests. Because reliable assays of clotting factors in the plasma of these animals are not available, standard curves were prepared using human reference plasma, and the clotting times were converted into units per liter of biological activity and compared with human plasma having an assigned value of 1.0 U/l coagulation factor. The results are, therefore, relative to the reference human plasma. The intra-assay coefficients of variation for factors VII, VIII:C, IX, X, and XI were 2.3, 2.4, 3,0, 3.6, and 5%, respectively.
Hematology and platelet indices
Hematologic and platelet parameters were determined in whole blood (EDTA-K 2 ) samples. The animal samples were analyzed using VetScan HM2 automated hematology analyzer (Abaxis Veterinary Diagnostics, Union City, California, USA), whereas human samples were analyzed using ABX Pentra 120 analyzer (Horiba ABX, Irvine, California, USA). The following parameters were determined: platelet count (PLT), plateletcrit (PCT), mean platelet volume (MPV), platelet distribution width (PDW), red blood cell count (RBC), hematocrit (HCT), mean corpuscular volume (MCV), and red cell blood cell distribution width index (RDW).
Statistical analysis
Results were analyzed using SAS version 8.1 for Windows (SAS Institute, Cary, North Carolina, USA). The Shapiro-Wilk normality test indicated all parameters were normally distributed. Significance was determined for results at P,0.01.
RESULTS
All subjects were clinically normal at sampling. Results of coagulation assays are presented in Table 1 . Because no significant differences were observed between male and female sand gazelles, those data were combined. The mean PT was significantly longer in sand gazelles when compared with either camels or humans, whereas the mean APTT was significantly shorter in both gazelles and camels than it was in humans. Both PT and APTT mean values were also significantly shorter in camels than they were in gazelles. Factor VII was comparable (P.0.05) in these two species and was significantly shorter than it was in humans. By contrast, factor VIII:C clotting activity was more than 7.5-fold higher in camels and more than 2.6-fold higher in gazelles than factor VIII:C in humans. Clotting factors IX, X, and XI, were comparable in sand gazelles, camels, and humans. No significant differences were found in plasma fibrinogen levels between gazelles and camels; however, in both species, fibrinogen was significantly higher than it was in humans.
Means, SEMs, and ranges of platelet counts, RBC counts, and their respective indices are presented in Table 2 . Platelet counts were significantly higher in sand gazelles than in either camels or humans, whereas PCT was significantly lower in camels than it was in either humans or gazelles. Significant differences were found among the three species with respect to MPV, PDW, RBC, MCV, and RDW. However, the HCT was comparable in sand gazelles and humans and, in both cases, was significantly higher than it was in camels.
DISCUSSION
This is the first report of the hemostatic profile and platelet indices of the Arabian sand gazelle. These results are important from a physiologic and clinical standpoint. In addition to hereditary coagulation disorders, hemostatic and platelet abnormalities are significant components of major pathological processes, including inflammation, infectious diseases, and immune-related diseases (Kristensen, 2004) . a PT 5 prothrombin time; APTT 5 activated partial thromboplastin time; VII 5 factor VII, proconvertin; VIII:C 5 factor VIII, antihemophilic factor, coagulation activity; IX 5 factor IX, plasma thromboplastin component; X 5 factor X, Stuart factor; XI 5 factor XI, plasma thromboplastin antecedent; Fib 5 fibrinogen.
We found similarities and differences in the hemostatic profiles of sand gazelles and camels, both of which are desert mammals indigenous to the Arabian Peninsula. Both species had shorter APTT values, higher fibrinogen and factor VIII:C levels, and lower factor VII, MPV, and PDW than those found in humans. The mean PT and APTT were also shorter in sand gazelles than previously reported for the Speke's gazelle (Travis and Eby, 2006) and longer than previously reported for the Arabian oryx (Hussein et al., 2009a) . The PT of the sand gazelles was also shorter than that reported for cattle (Bos taurus; Ç ö l and Uslu, 2006), sheep (Ovis aries; Joachim et al., 2003) , and goats (Capra hircus; Gutierrez et al., 1999) and similar to that reported for blackbucks (Antilope cervicapra; Hawkey, 1975) and equines (Equus spp; Thrall et al., 2004) , and higher than that reported for the llama (Lama glama) and alpaca (Vicugna pacos) (Summerfield et al., 2002) . Activated partial thromboplastin time was also markedly shorter in the sand gazelle when compared with cattle (Ç ö l and Uslu, 2006) and sheep (Joachim et al., 2003) , and slightly shorter than found for goats (Gutierrez et al., 1999) . Fibrinogen concentration of sand gazelles was similar to that reported in domestic ruminants (Phillips, 1984; Thrall et al., 2004) and oryx (Hussein et al., 2009a) . Camels and sand gazelles had markedly higher factor VIII:C activity than factor VIII:C in humans, with activity highest in camels; this pattern has also been recently observed in the oryx (Hussein et al., 2009a) . However, this does not seem to be a unique feature of desert ungulates because high factor VIII:C activities have also been reported for other mammals, including cattle, pigs (Sus scrofa), llama, dogs (Canis lupus familiaris), and particularly cats (felis catus; Mischke et al., 1995; Morin et al., 1995; Thrall et al., 2004; Zhang et al., 2008) . According to Morin et al. (1995) , it remains to be determined whether the high factor VIII:C activity in these species reflects an increased amount of this factor in their circulation or an increased sensitivity to activation by thrombin. Platelet indices, particularly MPV, PCT, and PDW, are important markers of platelet size, function, and reactivity and are, therefore, increasingly measured during routine blood counts (Hussein et al., 2009b) . Changes in these indices have been observed in a wide range of diseases in humans (Amin et al., 2004; Kaito et al., 2005; Ford et al., 2006; Kim et al., 2007; Tozkoparan et al., 2007; Catal et al., 2008; Ntaios et al., 2008; Ranjith et al., 2009; Ozhan et al., 2010; Yazici et al., 2010) and other animals (Sulivan et al., 1993; Segura et al., 2007; Tvedten et al., 2008; Yilmaz et al., 2008) . From a comparative standpoint, the mean PLT we report for the sand gazelle is higher than that recorded for the mountain gazelle (Gazella gazella) and lower than that recorded for the oryx (Hussein et al., 2009a, b) , whereas PCT, MPV, and PDW were similar in all three species. The mean PCT results for the sand gazelles was also higher than that reported for the Speke's gazelle (Travis and Eby, 2006) . Our results from sand gazelles and those results reported previously in mountain gazelles also show that the PCT value for both gazelle species is higher than that reported for sheep. In contrast, PCT and PDW results were lower in both gazelles than those reported for cattle (Hussein et al., 2009b) . We did not measure platelets directly. However, the low MPV and PDW values in the sand gazelle indicate that their blood platelets, like of those of camels (Lewis, 1976) , are less than the values for human platelets. This is the first published study to present data on blood coagulation and platelets variables of sand gazelles; however, further studies should be undertaken to expand our knowledge of these parameters, to investigate their variation with age and physiologic status, and to understand their potential role when diagnosing disease, determining prognosis, and monitoring the health status of these animals. 
